Dr Isabel Maria Rutzen-lopez, - Medicare Physical Medicine And Rehabilitation in San Juan, PR

Dr Isabel Maria Rutzen-lopez, is a medicare enrolled "Physical Medicine & Rehabilitation" physician in San Juan, Puerto Rico. She went to University Central Del Caribe Escuela De Medicina and graduated in 2011 and has 13 years of diverse experience with area of expertise as Physical Medicine And Rehabilitation. She is a member of the group practice Centro De Cancer De La Universidad, Grupo Fisiatrico Torre Auxilio Mutuo and her current practice location is Centro Medico, Bo Monacillos Ave Americo Miranda, San Juan, Puerto Rico. You can reach out to her office (for appointments etc.) via phone at (787) 763-4149.

Dr Isabel Maria Rutzen-lopez is licensed to practice in Puerto Rico (license number 018954) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1023302452.

Contact Information

Dr Isabel Maria Rutzen-lopez,
Centro Medico, Bo Monacillos Ave Americo Miranda,
San Juan, PR 00935
(787) 763-4149
(787) 999-4048



Physician's Profile

Full NameDr Isabel Maria Rutzen-lopez
GenderFemale
SpecialityPhysical Medicine And Rehabilitation
Experience13 Years
LocationCentro Medico, San Juan, Puerto Rico
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Isabel Maria Rutzen-lopez attended and graduated from University Central Del Caribe Escuela De Medicina in 2011
  NPI Data:
  • NPI Number: 1023302452
  • Provider Enumeration Date: 06/02/2011
  • Last Update Date: 07/26/2018
  Medicare PECOS Information:
  • PECOS PAC ID: 2860758273
  • Enrollment ID: I20171116003006

Medical Identifiers

Medical identifiers for Dr Isabel Maria Rutzen-lopez such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1023302452NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
208100000XPhysical Medicine & Rehabilitation 018954 (Puerto Rico)Primary
208D00000XGeneral Practice 18954 (Puerto Rico)Secondary

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Centro De Cancer De La Universidad711322038524
Grupo Fisiatrico Torre Auxilio Mutuo89210827855

News Archive

Researchers examine burden of HIV and sexually transmitted diseases in China

A new study by researchers at the Johns Hopkins Bloomberg School of Public Health examines the burden of HIV and sexually transmitted disease among male clients of the commercial sex industry in China's Sichuan province

Psychologists and sociologists investigate comparative optimism for infection and recovery from COVID-19

Until a vaccine and/or effective cure for COVID-19 becomes available, battling the current pandemic strongly relies on how well people follow behavioral advice, such as adhering to local restrictions, social distancing rules, and engaging in effective personal hygiene.

Important differences found in characteristics, progression of lupus among racial/ethnic groups

In the first epidemiologic study comparing lupus among four major racial/ethnic groups, researchers found that, following a lupus diagnosis, Blacks, Asians/Pacific Islanders, and Hispanics are at increased risk of developing problems related to the kidneys, the neurological system, and the blood.

Study reveals promising results for primary liver cancer patients treated with SIR-Spheres Y-90 resin microspheres

Patients with advanced or inoperable Hepatocellular Carcinoma (HCC) who usually received one or two treatments with liver-directed SIR-Spheres Y-90 resin microspheres in the 459-patient French SARAH study had similar survival compared to patients who received standard twice-daily systemic treatment with sorafenib, but with less than half the number and significantly fewer severe treatment-related adverse effects and significantly better Quality of Life, according to data presented here at The International Liver Congress™ 2017.

Read more Medical News

› Verified 8 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Isabel Maria Rutzen-lopez allows following entities to bill medicare on her behalf.
Entity NameGrupo Fisiatrico Torre Auxilio Mutuo
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1184613002
PECOS PAC ID: 8921082785
Enrollment ID: O20040617000988

News Archive

Researchers examine burden of HIV and sexually transmitted diseases in China

A new study by researchers at the Johns Hopkins Bloomberg School of Public Health examines the burden of HIV and sexually transmitted disease among male clients of the commercial sex industry in China's Sichuan province

Psychologists and sociologists investigate comparative optimism for infection and recovery from COVID-19

Until a vaccine and/or effective cure for COVID-19 becomes available, battling the current pandemic strongly relies on how well people follow behavioral advice, such as adhering to local restrictions, social distancing rules, and engaging in effective personal hygiene.

Important differences found in characteristics, progression of lupus among racial/ethnic groups

In the first epidemiologic study comparing lupus among four major racial/ethnic groups, researchers found that, following a lupus diagnosis, Blacks, Asians/Pacific Islanders, and Hispanics are at increased risk of developing problems related to the kidneys, the neurological system, and the blood.

Study reveals promising results for primary liver cancer patients treated with SIR-Spheres Y-90 resin microspheres

Patients with advanced or inoperable Hepatocellular Carcinoma (HCC) who usually received one or two treatments with liver-directed SIR-Spheres Y-90 resin microspheres in the 459-patient French SARAH study had similar survival compared to patients who received standard twice-daily systemic treatment with sorafenib, but with less than half the number and significantly fewer severe treatment-related adverse effects and significantly better Quality of Life, according to data presented here at The International Liver Congress™ 2017.

Read more Medical News

› Verified 8 days ago

Entity NameCentro De Rehabilitacion Y Medicina Del Deporte
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1649499294
PECOS PAC ID: 4183707227
Enrollment ID: O20080212000522

News Archive

Researchers examine burden of HIV and sexually transmitted diseases in China

A new study by researchers at the Johns Hopkins Bloomberg School of Public Health examines the burden of HIV and sexually transmitted disease among male clients of the commercial sex industry in China's Sichuan province

Psychologists and sociologists investigate comparative optimism for infection and recovery from COVID-19

Until a vaccine and/or effective cure for COVID-19 becomes available, battling the current pandemic strongly relies on how well people follow behavioral advice, such as adhering to local restrictions, social distancing rules, and engaging in effective personal hygiene.

Important differences found in characteristics, progression of lupus among racial/ethnic groups

In the first epidemiologic study comparing lupus among four major racial/ethnic groups, researchers found that, following a lupus diagnosis, Blacks, Asians/Pacific Islanders, and Hispanics are at increased risk of developing problems related to the kidneys, the neurological system, and the blood.

Study reveals promising results for primary liver cancer patients treated with SIR-Spheres Y-90 resin microspheres

Patients with advanced or inoperable Hepatocellular Carcinoma (HCC) who usually received one or two treatments with liver-directed SIR-Spheres Y-90 resin microspheres in the 459-patient French SARAH study had similar survival compared to patients who received standard twice-daily systemic treatment with sorafenib, but with less than half the number and significantly fewer severe treatment-related adverse effects and significantly better Quality of Life, according to data presented here at The International Liver Congress™ 2017.

Read more Medical News

› Verified 8 days ago

Entity NameGrupo Fisiatrico De Bayamon, Ptr
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1114932944
PECOS PAC ID: 7719017284
Enrollment ID: O20100609000590

News Archive

Researchers examine burden of HIV and sexually transmitted diseases in China

A new study by researchers at the Johns Hopkins Bloomberg School of Public Health examines the burden of HIV and sexually transmitted disease among male clients of the commercial sex industry in China's Sichuan province

Psychologists and sociologists investigate comparative optimism for infection and recovery from COVID-19

Until a vaccine and/or effective cure for COVID-19 becomes available, battling the current pandemic strongly relies on how well people follow behavioral advice, such as adhering to local restrictions, social distancing rules, and engaging in effective personal hygiene.

Important differences found in characteristics, progression of lupus among racial/ethnic groups

In the first epidemiologic study comparing lupus among four major racial/ethnic groups, researchers found that, following a lupus diagnosis, Blacks, Asians/Pacific Islanders, and Hispanics are at increased risk of developing problems related to the kidneys, the neurological system, and the blood.

Study reveals promising results for primary liver cancer patients treated with SIR-Spheres Y-90 resin microspheres

Patients with advanced or inoperable Hepatocellular Carcinoma (HCC) who usually received one or two treatments with liver-directed SIR-Spheres Y-90 resin microspheres in the 459-patient French SARAH study had similar survival compared to patients who received standard twice-daily systemic treatment with sorafenib, but with less than half the number and significantly fewer severe treatment-related adverse effects and significantly better Quality of Life, according to data presented here at The International Liver Congress™ 2017.

Read more Medical News

› Verified 8 days ago

Entity NameCentro De Cancer De La Universidad
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1215418751
PECOS PAC ID: 7113220385
Enrollment ID: O20210318001999

News Archive

Researchers examine burden of HIV and sexually transmitted diseases in China

A new study by researchers at the Johns Hopkins Bloomberg School of Public Health examines the burden of HIV and sexually transmitted disease among male clients of the commercial sex industry in China's Sichuan province

Psychologists and sociologists investigate comparative optimism for infection and recovery from COVID-19

Until a vaccine and/or effective cure for COVID-19 becomes available, battling the current pandemic strongly relies on how well people follow behavioral advice, such as adhering to local restrictions, social distancing rules, and engaging in effective personal hygiene.

Important differences found in characteristics, progression of lupus among racial/ethnic groups

In the first epidemiologic study comparing lupus among four major racial/ethnic groups, researchers found that, following a lupus diagnosis, Blacks, Asians/Pacific Islanders, and Hispanics are at increased risk of developing problems related to the kidneys, the neurological system, and the blood.

Study reveals promising results for primary liver cancer patients treated with SIR-Spheres Y-90 resin microspheres

Patients with advanced or inoperable Hepatocellular Carcinoma (HCC) who usually received one or two treatments with liver-directed SIR-Spheres Y-90 resin microspheres in the 459-patient French SARAH study had similar survival compared to patients who received standard twice-daily systemic treatment with sorafenib, but with less than half the number and significantly fewer severe treatment-related adverse effects and significantly better Quality of Life, according to data presented here at The International Liver Congress™ 2017.

Read more Medical News

› Verified 8 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Isabel Maria Rutzen-lopez is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Isabel Maria Rutzen-lopez,
Condominio Santa Maria, 139 Carr 177 Apt 802,
San Juan, PR 00926-5351

Ph: (787) 365-8596
Dr Isabel Maria Rutzen-lopez,
Centro Medico, Bo Monacillos Ave Americo Miranda,
San Juan, PR 00935

Ph: (787) 763-4149

News Archive

Researchers examine burden of HIV and sexually transmitted diseases in China

A new study by researchers at the Johns Hopkins Bloomberg School of Public Health examines the burden of HIV and sexually transmitted disease among male clients of the commercial sex industry in China's Sichuan province

Psychologists and sociologists investigate comparative optimism for infection and recovery from COVID-19

Until a vaccine and/or effective cure for COVID-19 becomes available, battling the current pandemic strongly relies on how well people follow behavioral advice, such as adhering to local restrictions, social distancing rules, and engaging in effective personal hygiene.

Important differences found in characteristics, progression of lupus among racial/ethnic groups

In the first epidemiologic study comparing lupus among four major racial/ethnic groups, researchers found that, following a lupus diagnosis, Blacks, Asians/Pacific Islanders, and Hispanics are at increased risk of developing problems related to the kidneys, the neurological system, and the blood.

Study reveals promising results for primary liver cancer patients treated with SIR-Spheres Y-90 resin microspheres

Patients with advanced or inoperable Hepatocellular Carcinoma (HCC) who usually received one or two treatments with liver-directed SIR-Spheres Y-90 resin microspheres in the 459-patient French SARAH study had similar survival compared to patients who received standard twice-daily systemic treatment with sorafenib, but with less than half the number and significantly fewer severe treatment-related adverse effects and significantly better Quality of Life, according to data presented here at The International Liver Congress™ 2017.

Read more News

› Verified 8 days ago


Physical Medicine & Rehabilitation Doctors in San Juan, PR

Dr. Jorge Luis Rodriguez-saenz, MD
Physical Medicine & Rehabilitation
Medicare: May Accept Medicare Assignments
Practice Location: 1451 Ave Ashford, San Juan, PR 00907
Phone: 787-722-2915    
Dr. Luis N Olmedo, MD
Physical Medicine & Rehabilitation
Medicare: Not Enrolled in Medicare
Practice Location: Street 3 S-13 Villas De Parana, San Juan, PR 00926
Phone: 787-667-0411    
Victor Josue Rosado Torres, MD
Physical Medicine & Rehabilitation
Medicare: Medicare Enrolled
Practice Location: Hospital Oncologico Dr Isaac Gonzalez Martinez, Centro Medico Bo Monacillo, San Juan, PR 00935
Phone: 787-763-4149    
Dr. Isabel Cristina Borras, M.D.
Physical Medicine & Rehabilitation
Medicare: Not Enrolled in Medicare
Practice Location: 10 Calle Casia, Veterans Hospital Administration, San Juan, PR 00921
Phone: 787-641-7582    
Dr. Priscilla Mieses Llavat, MD
Physical Medicine & Rehabilitation
Medicare: Accepting Medicare Assignments
Practice Location: Ashford Medical Ctr, Suite 409, San Juan, PR 00907
Phone: 787-722-3955    
Dr. Walter R Frontera, MD, PHD
Physical Medicine & Rehabilitation
Medicare: Medicare Enrolled
Practice Location: 2 Calle Azucena, Santa Maria, San Juan, PR 00927
Phone: 787-309-5060    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.